Future of AstraZeneca COVID-19 vaccine in question in Canada over blood clots, supply issues
Published
The future use of the AstraZeneca-Oxford COVID-19 vaccine in Canada is now in question due to concerns over the increased risk of rare but severe blood clots connected to the shot, an unpredictable future supply and a significant amount of alternative vaccines.
Full Article